Medidata Solutions

Medidata Solutions provides cloud-based solutions for clinical research in life sciences. The company's cloud-based platform of solutions and data analytics enables improvement throughout clinical development programs. The company provides its technology on an enterprise or multi-study basis. The company's services include: implementation services, which provide implementation of the Medidata Clinical Cloud with configuration and implementation support to its customers; sponsor enablement, which enables customers to design, configure, implement, and manage their own studies; and strategic consulting, which supports a re-engineered development process that require its customers to implement internal changes.
  • TickerMDSO
  • ISINUS58471A1051
  • ExchangeNASDAQ Stock Market
  • SectorSoftware & Computer Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

Valens Research

UAFRS vs As Reported Weekly Highlights - 2019 06 12

This week, Valens identified distortions and the corresponding adjustments to correct for those distortions for IQV, MDSO, and WSP:CAN.

Jonathan Moreland

InsiderInsights Daily Ratings Report: October 25, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

ValuEngine Rating and Forecast Report for MDSO

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Gold appears to be developing a potential head-and-shoulders bottom. A break above the $128 level would be very bullish. (ex. GLD and GDX) • A number of restaurants are bullishly inflecting, trending up and to the right. (ex. JACK, DIN, SHAK, and YUM) • REIT's continue to be leadership (ex. PSB, HCP, HR, WELL, ARE, ESS, MAA, AMT, CCI, and SBAC)

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

As higher lows continue within a broader YTD sideways consolidation, the S&P 500 is poised to retest the 2,790-2,800 horizontal resistance level that we have highlighted in previous reports. While we continue to expect the broad YTD consolidation to continue, below we highlight additional factors that lead to our overall constructive outlook: • XLF bouncing off critical support with authority. We have voiced our concern regarding a potential breakdown below $26.50 on the XLF and the negative implications that it would have on the broad market. We have also noted a failure to break down woul...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch